Correction: Serum biomarker for diagnostic evaluation of pulmonary arterial hypertension in systemic sclerosis
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1478-6362
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Correction: Serum biomarker for diagnostic evaluation of pulmonary arterial hypertension in systemic sclerosis ; volume:24 ; number:1 ; day:23 ; month:5 ; year:2022 ; pages:1 ; date:12.2022
Arthritis Research & Therapy ; 24, Heft 1 (23.5.2022), 1, 12.2022
- Creator
-
Rice, Lisa M.
Mantero, Julio C.
Stratton, Eric A.
Warburton, Rod
Roberts, Kari
Hill, Nicholas
Simms, Robert W.
Domsic, Robyn
Farber, Harrison W.
Lafyatis, Robert
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s13075-022-02816-8
- URN
-
urn:nbn:de:101:1-2022072619070297071858
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:26 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Rice, Lisa M.
- Mantero, Julio C.
- Stratton, Eric A.
- Warburton, Rod
- Roberts, Kari
- Hill, Nicholas
- Simms, Robert W.
- Domsic, Robyn
- Farber, Harrison W.
- Lafyatis, Robert
- SpringerLink (Online service)
Other Objects (12)
Serum biomarker for diagnostic evaluation of pulmonary arterial hypertension in systemic sclerosis
Interleukin-32 in systemic sclerosis, a potential new biomarker for pulmonary arterial hypertension
Early treatment of borderline pulmonary arterial hypertension associated with systemic sclerosis
Variants of PBEF predispose to systemic sclerosis and pulmonary arterial hypertension development
The economic burden of systemic sclerosis related pulmonary arterial hypertension in Australia
Relapsing polychondritis presenting 2 years after systemic sclerosis with pulmonary arterial hypertension
Stress Doppler echocardiography for early detection of systemic sclerosis-associated pulmonary arterial hypertension
Survival and quality of life in incident systemic sclerosis-related pulmonary arterial hypertension
Serum VEGF levels are related to the presence of pulmonary arterial hypertension in systemic sclerosis
Pulmonary blood density in systemic sclerosis – a novel non-invasive measure of pulmonary arterial hypertension?
Impact of interstitial lung disease on the survival of systemic sclerosis with pulmonary arterial hypertension
Cytokine signatures differentiate systemic sclerosis patients at high versus low risk for pulmonary arterial hypertension
Serum biomarker for diagnostic evaluation of pulmonary arterial hypertension in systemic sclerosis
Interleukin-32 in systemic sclerosis, a potential new biomarker for pulmonary arterial hypertension
Early treatment of borderline pulmonary arterial hypertension associated with systemic sclerosis
Variants of PBEF predispose to systemic sclerosis and pulmonary arterial hypertension development
The economic burden of systemic sclerosis related pulmonary arterial hypertension in Australia
Relapsing polychondritis presenting 2 years after systemic sclerosis with pulmonary arterial hypertension
Stress Doppler echocardiography for early detection of systemic sclerosis-associated pulmonary arterial hypertension
Survival and quality of life in incident systemic sclerosis-related pulmonary arterial hypertension
Serum VEGF levels are related to the presence of pulmonary arterial hypertension in systemic sclerosis
Pulmonary blood density in systemic sclerosis – a novel non-invasive measure of pulmonary arterial hypertension?
Impact of interstitial lung disease on the survival of systemic sclerosis with pulmonary arterial hypertension
Cytokine signatures differentiate systemic sclerosis patients at high versus low risk for pulmonary arterial hypertension
Serum biomarker for diagnostic evaluation of pulmonary arterial hypertension in systemic sclerosis
Interleukin-32 in systemic sclerosis, a potential new biomarker for pulmonary arterial hypertension
Early treatment of borderline pulmonary arterial hypertension associated with systemic sclerosis
Variants of PBEF predispose to systemic sclerosis and pulmonary arterial hypertension development
The economic burden of systemic sclerosis related pulmonary arterial hypertension in Australia
Relapsing polychondritis presenting 2 years after systemic sclerosis with pulmonary arterial hypertension
Stress Doppler echocardiography for early detection of systemic sclerosis-associated pulmonary arterial hypertension
Survival and quality of life in incident systemic sclerosis-related pulmonary arterial hypertension
Serum VEGF levels are related to the presence of pulmonary arterial hypertension in systemic sclerosis
Pulmonary blood density in systemic sclerosis – a novel non-invasive measure of pulmonary arterial hypertension?
Impact of interstitial lung disease on the survival of systemic sclerosis with pulmonary arterial hypertension